Bioactive Compounds
-
BA1913 TrilobatinSummary: Trilobatin is a sweetener derived from Rehd, Trilobatin is an inhibitor that targets the Gp41 envelope protein. - BA1912 LDC4297Summary: LDC4297 is a selective inhibitor.
- BA1910 CyclotriazadisulfonamideSummary: Cyclotriazadisulfonamide (CADA) is a specifically targeted entry inhibitor.
- BA1909 GPI-1046Summary: GPI-1046, an immunoaffinity ligand without antibiotic effects, reduces ethanol intake by upregulating glutamate transporter protein 1 in the PFC and NAc core.
- BA1908 MS417Summary: MS417 is a selective inhibitor of BET-specific proteins.
- BA1906 DDX3-IN-2Summary: DDX3-IN-2 is an active DEADboxpolypeptide3 inhibitor with a value of 0.3 μM.
- BA1905 PF-3450074Summary: PF-3450074 (PF-74) is a specific inhibitor of the HIV-1 coat protein and exhibits broad-spectrum inhibition of isolates
- BA1904 MitoguazoneSummary: Mitoguazone (Methylglyoxal-bis(guanylhydrazone)) is a synthetic polycarbony derivative with potent antitumor activity.
- BA1903 BRD-6929Summary: BRD-6929 is a class I histone deacetylase and brain permeability selective inhibitor.
- BA1902 Ro24-7429Summary: Ro24-7429 is a potent and orally active HIV-1 trans-activator protein antagonist.